• Ownership

Mark C. McKenna - Insider Trading & Ownership

Entity
Individual
Location
400 Somerset Corporate Boulevard, Bridgewater, NJ
Summary
The estimated net worth of Mark C. McKenna is at least $1.17M dollars as of January 8, 2025. Mark C. McKenna is the Director of Apogee Therapeutics, Inc. and owns shares of Apogee Therapeutics, Inc. (APGE) stock worth about $997K. Mark C. McKenna is the Director of NewAmsterdam Pharma Co N.V. and owns shares of NewAmsterdam Pharma Co N.V. (NAMS) stock worth about $178K.
All Insider Reports
All Insider Reports

Ownership of Mark C. McKenna

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
APGE Apogee Therapeutics, Inc. Director $997K +$991K +15916% Dec 12, 2024
NAMS, NAMSW NewAmsterdam Pharma Co N.V. Director $178K Jan 6, 2025
HLXB Helix Acquisition Corp. II Director Feb 8, 2024
PCSC Perceptive Capital Solutions Corp Director Jun 11, 2024
RXDX Prometheus Biosciences, Inc. Chairman, President and CEO, Director Jun 16, 2023
SYRE Spyre Therapeutics, Inc. Director Feb 1, 2024

Insider Transactions Reported by Mark C. McKenna:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.